DATE: January 18, 2018
TIME: 08:00am PST, 11:00am EST

Current exon-level arrays and NGS techniques for CNV detection are plagued with a high number of false-positive calls and are challenging from a cost perspective when verifying numerous exon aberrations with orthogonal methods. Relevant gene lists continue to grow such that custom del/dup arrays out-date quickly and create laboratory inefficiencies with implementation and verification of new designs. These are only a few of the pain-points users experience given the current options in the marketplace for exon-level CNV analysis.

Children's National Medical Center and Greenwood Genetic Center utilize a new, research tool for exon-level CNV detection, the Applied Biosystems™ CytoScan™ XON Suite. This tool comprehensively detects single-exon deletions and duplications in a cost-effective manner and can be used to complement NGS mutation analysis with its reliable exon-level CNV detection. This unique solution offers reporting flexibility whereby you may utilize your preferred gene list or customize your analysis to include various gene-level tiers selected for clinical research relevance. Thus, the user determines the areas of interest and is able to expand or restrict analysis for reporting.

Both Children's National Medical Center and Greenwood Genetic Center were early access sites for the new CytoScan XON Suite and will be sharing their perspective, experience, and research cases thus far.

Learning Objectives:

• Understand the current challenges of exon-level analysis
• Understand how a novel exon-level CNV assay can be used to overcome these challenges
• Identify research cases that may benefit from an exon-level CNV assay

For Research Use Only. Not for use in diagnostic procedures.